Bio-Rad Labs: Things are changing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio-Rad Labs: Things are changing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jsabelko who wrote (11)	2/28/2000 10:18:00 PM
From: Dave Chanoux	Read Replies (2) of 18

Thanks so much for the comments. It sure is nice to know that someone else has an interest. I've been a Bio-Rad owner off and on (mostly on) for about 5 years. I find the PSD activity very positive as I have implied for the last 10 posts or so. When I made the most recent Bio-Rad investment last fall, I looked at Conmed and Boston Scientific as well but did not invest there. Everyone has their own objectives, risk tolerances etc. If you could put me in a category, it would probably be "value" as I focus on low-PE-ratio shares and do well when PE ratios increase with growing earnings. I have also owned Genzyme shares (and still do) which have more than doubled in the last 2-3 years. Most aggressive investors would not consider Genzyme a good investment, but it has been good for me. Biology is changing and Bio-Rad is finally taking action to change along with it. Much information is coming out of the Human Genome project and there will be much more opportunity in the future. Notice Bio-Rad's increased press activity since the PSD acquisition. No analysts cover the company, but I suspect some will and when that occurs, values may increase some. Regards, Dave Chanoux

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next